Ubs Group Ag Sight Sciences, Inc. Call Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SGHT
# of Institutions
81Shares Held
21.6MCall Options Held
66.8KPut Options Held
13K-
Kck Ltd. Tortola, D84.65MShares$16.6 Million22.26% of portfolio
-
Black Rock Inc. New York, NY2.12MShares$7.57 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.1MShares$7.51 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$6.04 Million0.0% of portfolio
-
Jackson Square Partners, LLC San Francisco, CA918KShares$3.28 Million0.5% of portfolio
About Sight Sciences, Inc.
- Ticker SGHT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,826,200
- Market Cap $171M
- Description
- Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...